Drugs / metronomic CPA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02387125 | Feb 2015 → Mar 2019 | melanoma, non-small cell lung carcinoma, ovarian cancer, sarcoma | Immune Design | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | metronomic CPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02387125 ↗ |
| Route | Oral | “oral metronomic CPA” NCT02387125 ↗ |